293 related articles for article (PubMed ID: 21717405)
1. Clinical observations and hormone screenings of patients with non-standard hypertrophy of the adrenal cortex.
Franik G; Skałba P
Endokrynol Pol; 2011; 62(3):230-7. PubMed ID: 21717405
[TBL] [Abstract][Full Text] [Related]
2. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
3. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
[TBL] [Abstract][Full Text] [Related]
4. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
Rudnicka E; Kunicki M; Radowicki S
Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
6. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
7. Value of buserelin testing in the evaluation of hirsute women.
Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
[TBL] [Abstract][Full Text] [Related]
8. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
[TBL] [Abstract][Full Text] [Related]
10. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.
Unluhizarci K; Gokce C; Atmaca H; Bayram F; Kelestimur F
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):504-9. PubMed ID: 15505757
[TBL] [Abstract][Full Text] [Related]
11. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
12. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
13. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
Luboshitzky R; Ishai A; Shen-Or Z; Herer P
Neuro Endocrinol Lett; 2003; 24(3-4):249-54. PubMed ID: 14523365
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
Sahmay S; Tuten A; Gurleyen H; Oncul M; Benian A; Tamer Erel C
Minerva Endocrinol; 2014 Sep; 39(3):215-22. PubMed ID: 25068307
[TBL] [Abstract][Full Text] [Related]
17. Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions.
Tuten A; Sahmay S; Oncul M; Acikgoz AS; Imamoglu M; Gurleyen HC; Senturk ML
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():121-5. PubMed ID: 24768424
[TBL] [Abstract][Full Text] [Related]
18. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
19. Sexual orientations of women with polycystic ovary syndrome: clinical observation in Taiwan.
Chen CH; Wang PH; Hsieh MT; Tzeng CR; Wu YH; Lee CS; Chu YH; Chang HY
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):542-6. PubMed ID: 25510698
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
Rachoń D
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):205-9. PubMed ID: 22421986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]